Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-04-10 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于回购注销部分限制性股票暨减资的债权人公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement by the company SanNuo Biological Sensor Co., Ltd. regarding the repurchase and cancellation of restricted shares and a reduction of capital, including a creditor notice. It details the process for creditors to declare their claims within a specified period. The content focuses on a corporate action related to share repurchase and capital reduction, with instructions for creditors, rather than financial results, management changes, or regulatory filings. The document length is short (1323 characters), and it is an announcement of a corporate action involving share repurchase and cancellation of restricted stock. This fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or share cancellations.
2017-04-10 Chinese
关于拟回购注销公司股权激励计划全部剩余股票期权与限制性股票的公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement from a company regarding the repurchase and cancellation of remaining stock options and restricted stocks under its equity incentive plan. It includes extensive historical context about the equity incentive plan, board meeting resolutions, specific quantities and prices of stock options and restricted stocks being repurchased and cancelled, and legal and supervisory opinions. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is also not a call transcript, earnings release, or governance report. The content focuses on the company's capital structure changes specifically related to stock option and restricted stock cancellations, which is a capital change event. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is the actual announcement, not a brief notice or regulatory filing. Confidence is high due to the specificity and detailed nature of the content about share repurchase and cancellation under an equity incentive plan.
2017-04-10 Chinese
《公司章程》修订对照说明
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from the board of directors of 三诺生物传感股份有限公司 regarding amendments to the company's Articles of Association (公司章程). It details the reduction of registered capital and the corresponding changes in share capital and share count due to the repurchase and cancellation of restricted shares. The document is short (777 characters) and primarily serves to inform shareholders and the public about these changes and the board's approval. It does not contain detailed financial statements, audit information, or comprehensive report data. It is not a full annual or interim report, nor is it a proxy solicitation or voting result announcement. The content fits best under a capital structure change announcement, specifically a share capital change due to repurchase and cancellation of shares, which aligns with the category 'Share Issue/Capital Change' (SHA).
2017-04-10 Chinese
第三届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fifth meeting of the third board of directors of SanNuo Biological Sensor Co., Ltd. It details the meeting date, attendees, agenda items, and voting results. The key topics include approval of a stock option and restricted stock repurchase and cancellation plan, and a reduction in registered capital with corresponding amendments to the company bylaws. The document is an official board meeting resolution announcement, not a full annual report, audit report, or financial statement. It does not contain financial statements or detailed financial analysis but focuses on board decisions and governance matters. Therefore, it fits the category of Board/Management Information (MANG). The document length is 1872 characters, which is short and typical for a board meeting resolution announcement. Confidence is high due to clear identification of board meeting resolutions and voting results related to management decisions.
2017-04-10 Chinese
北京国枫律师事务所关于公司股票期权与限制性股票激励计划注销股票期权/回购注销限制性股票与预留部分限制性股票相关事项的法律意见书
Audit Report / Information Classification · 95% confidence The document is a legal opinion letter issued by Beijing Grandway Law Offices regarding the cancellation and repurchase of stock options and restricted stock under an equity incentive plan of SanNuo Biological Sensor Co., Ltd. It references specific legal regulations, company resolutions, and audit reports to support the legality and compliance of the stock option and restricted stock cancellation and repurchase. The document is a standalone legal opinion on a specific corporate action related to stock incentives, not a full annual or interim financial report, earnings release, or management discussion. It does not contain financial statements or comprehensive financial data but focuses on legal compliance and procedural matters of the stock incentive plan. Therefore, it fits best under the category of Audit Report / Information (AR), which includes applied accounting principles and regulatory or internal compliance reports related to corporate actions, excluding full annual reports.
2017-04-10 Chinese
第三届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the fourth meeting of the third Supervisory Board of SanNuo Biological Sensor Co., Ltd. It details the meeting attendance, the voting results, and the decision to repurchase and cancel stock options and restricted shares. The document includes specific financial figures related to the company's net profit and the repurchase price, but it does not contain comprehensive financial statements or detailed financial analysis. The document is an official announcement of a board meeting decision rather than a full financial report or audit. It is also not a regulatory filing or certification letter. Given the content focuses on a board meeting resolution, it fits best under Board/Management Information (MANG). The document length is short (1393 characters), and it is not an announcement of a report publication but a meeting resolution announcement.
2017-04-10 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.